These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 17504833)

  • 21. Ethical ideology and product confidence: future pharmacists' attitudes toward generic drug substitution.
    Pelton LE; Smith MC
    Health Mark Q; 1991; 8(3-4):181-92. PubMed ID: 10111968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assessment of patient and pharmacist knowledge of and attitudes toward reporting adverse drug events due to formulation switching in patients with epilepsy.
    McAuley JW; Chen AY; Elliott JO; Shneker BF
    Epilepsy Behav; 2009 Jan; 14(1):113-7. PubMed ID: 18768168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
    Liow K; Barkley GL; Pollard JR; Harden CL; Bazil CW;
    Neurology; 2007 Apr; 68(16):1249-50. PubMed ID: 17438213
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment: generic substitution for antiepileptic medication. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 1990 Nov; 40(11):1641-3. PubMed ID: 2234417
    [No Abstract]   [Full Text] [Related]  

  • 26. Generic products of antiepileptic drugs (AEDs): is it an issue?
    Bialer M
    Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generic vs. brand name drugs--quality, not cost, is key issue.
    Stetler CJ
    Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133
    [No Abstract]   [Full Text] [Related]  

  • 28. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
    Bongiorno RA; Nutescu EA
    Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generic substitution in the treatment of epilepsy: patient attitudes and perceptions.
    Ngo SN; Stupans I; McKinnon RA
    Epilepsy Behav; 2013 Jan; 26(1):64-6. PubMed ID: 23220461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic versus branded pharmacotherapy in Parkinson's disease: does it matter? A review.
    Go CL; Rosales RL; Schmidt P; Lyons KE; Pahwa R; Okun MS
    Parkinsonism Relat Disord; 2011 Jun; 17(5):308-12. PubMed ID: 21367644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A political economy perspective: why pharmacists may be reluctant to dispense generic medications.
    Pelton LE; Strutton D; Smith MC
    J Hosp Mark; 1994; 9(1):137. PubMed ID: 10142135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substituting generic drugs: state roles.
    Cauchi R
    NCSL Legisbrief; 2009; 17(25):1-2. PubMed ID: 19526654
    [No Abstract]   [Full Text] [Related]  

  • 33. Liability of the pharmacist as a therapeutic consultant.
    Fink JL
    Am J Hosp Pharm; 1981 Feb; 38(2):218-22. PubMed ID: 7211885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription drug product substitution decision support.
    Manolakis PG
    J Am Pharm Assoc (2003); 2007; 47(3):328-38. PubMed ID: 17510028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epilepsy in the elderly: medications and pharmacokinetics.
    Marasco RA; Ramsay RE
    Consult Pharm; 2009 May; 24 Suppl A():10-6. PubMed ID: 19555150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of specifying brand-name antiepileptic drugs.
    Ng YT
    Arch Neurol; 2009 Nov; 66(11):1415-6. PubMed ID: 19901176
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioequivalence of antiepileptic drugs: how close is close enough?
    Gidal BE
    Curr Neurol Neurosci Rep; 2009 Jul; 9(4):333-7. PubMed ID: 19515287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacist's progress toward implementing pharmaceutical care.
    Trinca CE
    Am Pharm; 1995; Suppl():13-8. PubMed ID: 7677060
    [No Abstract]   [Full Text] [Related]  

  • 40. Generic vs. brand name drugs--defining and enforcing standards.
    Lasagna LC
    Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.